Bone Biologics Corp. Operating Income Growth

Operating Income Growth of BBLG for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Income Growth for the quarter ending September 30, 2022 was -430.59% (a 320.62% increase compared to previous quarter)
  • Annual Operating Income Growth for 2021 was -33.52% (a -150.57% decrease from previous year)
  • Annual Operating Income Growth for 2020 was 66.29% (a -133.71% decrease from previous year)
Visit stockrow.com/BBLG for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income Growth of Bone Biologics Corp.

Most recent Operating Income Growthof BBLG including historical data for past 10 years.

Interactive Chart of Operating Income Growth of Bone Biologics Corp.

Bone Biologics Corp. Operating Income Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -430.59% -102.37% -262.85%
2021 -33.52%
2020 66.29%
2019 -196.65%

Business Profile of Bone Biologics Corp.

Sector: Healthcare
Industry: Medical Devices